Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review.

Autor: Lin DH; Department of Epidemiology, 25802Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Murimi-Worstell IB; Department of Epidemiology, 25802Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Kan H; Department of Health Policy and Management, 25802Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Tierce JC; Department of Epidemiology, 25802Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Wang X; Data Science & Artificial Intelligence, BioPharmaceuticals R&D, 468090AstraZeneca, Gaithersburg, MD, USA., Nab H; Inflammation & Autoimmunity, BioPharmaceuticals Medical, 468087AstraZeneca, Cambridge, UK., Desta B; Global Pricing and Market Access, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Hammond ER; Epidemiology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Alexander GC; Center for Drug Safety and Effectiveness, 25802Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Publikováno v: Lupus [Lupus] 2022 Jun; Vol. 31 (7), pp. 773-807. Date of Electronic Publication: 2022 Apr 25.

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers.

Autor: Heyward J; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Jones CM; Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC., Compton WM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland., Lin DH; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Losby JL; Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention, Atlanta, Georgia., Murimi IB; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Baldwin GT; Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention, Atlanta, Georgia., Ballreich JM; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Thomas DA; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland., Bicket MC; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland., Porter L; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland., Tierce JC; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Alexander GC; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland.

Publikováno v: JAMA network open [JAMA Netw Open] 2018 Oct 05; Vol. 1 (6), pp. e183044. Date of Electronic Publication: 2018 Oct 05.

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.

Autor: Lin DH; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Jones CM; Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC., Compton WM; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland., Heyward J; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Losby JL; Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Murimi IB; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Baldwin GT; Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia., Ballreich JM; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Thomas DA; National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland., Bicket M; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland., Porter L; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland., Tierce JC; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Alexander GC; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland.

Publikováno v: JAMA network open [JAMA Netw Open] 2018 Jun 01; Vol. 1 (2), pp. e180235. Date of Electronic Publication: 2018 Jun 01.

Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients.

Autor: Tierce JC; ValueMedics Research LLC, Arlington, VA, USA., Porterfield-Baxa J, Petrilla AA, Kilburg A, Ferguson RM

Publikováno v: Clinical transplantation [Clin Transplant] 2005 Dec; Vol. 19 (6), pp. 779-84.

Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.

Autor: Benner JS; ValueMedics Research, LLC, Arlington, VA, and University of Maryland, Baltimore, MD, USA. josh.benner@valuemedics.com, Smith TW, Klingman D, Tierce JC, Mullins CD, Pethick N, O'Donnell JC

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2005 Nov-Dec; Vol. 8 (6), pp. 618-28.